Viewing Study NCT00116961


Ignite Creation Date: 2025-12-24 @ 12:02 PM
Ignite Modification Date: 2026-02-22 @ 4:52 PM
Study NCT ID: NCT00116961
Status: COMPLETED
Last Update Posted: 2012-02-07
First Post: 2005-06-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
Sponsor: University of Michigan Rogel Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module